Table 2.
OR | 95% CI | p value | |
---|---|---|---|
Tumor stage | |||
Stage 1 | 1.0 | p = 0.001 | |
Stage 2 | 2.6 | 1.3–5.2 | |
Stage 3 | 3.3 | 1.5–7.0 | |
Stage 4 | 2.4 | 1.4–4.3 | |
Tumor site | |||
Larynx | 1.0 | p = 0.013 | |
Pharynx | 1.9 | 1.0–3.3 | |
Oral cavity | 2.1 | 1.2–3.7 | |
Other | 3.3 | 1.1–9.7 |
Age, sex, and treatment modality were not significantly associated with usage rate, and therefore not included in these analyses. Number of patients in these analyses is smaller (N = 407) than the total study population (N = 449) because of missing data on tumor stage